Strongbridge Biopharma plc Provides Update on Corporate Progress
Mar 07, 2016 12:30 pm UTC| Business
Strongbridge Prioritizes Rare Endocrine Disease Portfolio Focus on COR-003 and COR-005 Strongbridge Provides Update on Cash Position – Existing Cash Sufficient to Fund Planned Operations Beyond Receipt of Data From...
TG Therapeutics, Inc. to Present at Upcoming Investment Conferences
Mar 07, 2016 12:30 pm UTC| Business
NEW YORK, March 07, 2016 -- TG Therapeutics, Inc. (Nasdaq:TGTX) today announced its participation at two upcoming investment conferences. Michael S. Weiss, the Company’s Executive Chairman and Interim Chief Executive...
Alliqua BioMedical, Inc. Announces Expansion of Medicare Reimbursement Coverage for Biovance®
Mar 07, 2016 12:30 pm UTC| Business
YARDLEY, Pa., March 07, 2016 -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, today announced that Biovance® Human Amniotic Membrane Allograft is now...
Marinus Pharmaceuticals Provides Business Update and 2015 Financial Results
Mar 07, 2016 12:30 pm UTC| Business
RADNOR, Pa., March 07, 2016 -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today...
Mar 07, 2016 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 07, 2016 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...
Aehr Test Systems to Exhibit at Burn-in and Test Strategies Workshop in Mesa, AZ March 6-9
Mar 07, 2016 12:30 pm UTC| Business
FREMONT, Calif., March 07, 2016 -- Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that it will exhibit in Booth A28 at the 17th annual Burn-in and Test...
Spark Therapeutics Announces Acquisition of Genable Technologies
Mar 07, 2016 12:20 pm UTC| Business
PHILADELPHIA, March 07, 2016 -- Spark Therapeutics (NASDAQ:ONCE) today announced that it has acquired Dublin, Ireland-based Genable Technologies, a private gene therapy innovator with which Spark has collaborated since...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects